The Charlson comorbidity index can be used prospectively to identify patients who will incur high future costs

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Charlson, Mary ^a   Wells, Martin T ^b   Ullman, Ralph ^c   King, Fionnuala ^c   Shmukler, Celia ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Department of Statistical Science Cornell University ^*  (United States)

^c 1199SEIU Benefit and Pension Funds ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ASTHMA; CELLULITIS; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COST; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC COST GROUP; FEMALE; HEALTH CARE COST; HEART INFARCTION; HEMIPLEGIA; HISPANIC; HOSPITALIZATION; HUMAN; HYPERTENSION; INFANT; LEUKEMIA; LYMPHOMA; MALE; MILD HEPATIC IMPAIRMENT; MODERATE RENAL IMPAIRMENT; PERIPHERAL VASCULAR DISEASE; PREDICTOR VARIABLE; PRESCHOOL CHILD; RHEUMATIC DISEASE; SCHOOL CHILD; SEVERE HEPATIC IMPAIRMENT; SEVERE RENAL IMPAIRMENT; SKIN ULCER; SOLID TUMOR; ULCER; CHRONIC DISEASE; CLINICAL TRIAL; ECONOMICS; MIDDLE AGED; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL MODEL; TRENDS; YOUNG ADULT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; MALE; MIDDLE AGED; MODELS, ECONOMIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84916239466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112479     Document Type: Article

References (46)

1. Claxton G, DiJulio B, Whitmore H, Pickreign JD, McHugh M, et al. (2010) Health benefits in 2010: premiums rise modestly, workers pay more toward coverage. Health Aff (Millwood) 29: 1942-50.
2. (2012) Employer Health Benefits Survey: Kaiser Family Foundation/Health Research and Educational Trust.
3. Lee J, Anderson T (2005) High Cost Medicare Beneficiaries. Washington DC: Congressional Budget Office.
4. Arora RR, Boehm J, Chimento L, Moldawer L, Tsien C (2008) Designing and implementing Medicaird Disease and Care Management Programs: A User's Guide.
5. Li J, Holmes AM, Rosenman MB, Katz BP, Downs SM, et al. (2005) Indiana chronic disease management program risk stratification analysis. Med Care 43: 979-84.
6. Rula E, Hobgood A, Hamlet K, Zeng H, Montijo M (2009) Maximizing care management savings through advanced total population targeting. Outcomes and Insights in Health Management 1: 1-5.
7. Forrest CB, Lemke KW, Bodycombe DP, Weiner JP (2009) Medication, diagnostic, and cost information as predictors of high-risk patients in need of care management. The American journal of managed care 15: 41-8.
8. Vogeli C, Shields AE, Lee TA, Gibson TB, Marder WD, et al. (2007) Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med 22 Suppl 3: 391-5.
9. Parekh AK, Goodman RA, Gordon C, Koh HK (2011) Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep 126: 460-71.
10. Application Guidelines. (18 Oct 2012) Patient-Centered Outcomes Research Institute.
11. Parekh AK, Barton MB (2010) The challenge of multiple comorbidity for the US health care system. Jama 303: 1303-4.
12. Huntley AL, Johnson R, Purdy S, Valderas JM, Salisbury C (2012) Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Annals of family medicine 10: 134-41.
13. Di Bari M, Virgillo A, Matteuzzi D, Inzitari M, Mazzaglia G, et al. (2006) Predictive validity of measures of comorbidity in older community dwellers: the Insufficienza Cardiaca negli Anziani Residenti a Dicomano Study. J Am Geriatr Soc 54: 210-6.
14. Goodman RA, Parekh AK, Koh HK (2012) Toward a more cogent approach to the challenges of multimorbidity. Annals of family medicine 10: 100-1.
15. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56: 221-9.
16. Tinetti ME, Basu J (2014) Research on multiple chronic conditions: where we are and where we need to go. Med Care 52 Suppl 3: S3-6.
17. Leroy L, Bayliss E, Domino M, Miller BF, Rust G, et al. (2014) The Agency for Healthcare Research and Quality Multiple Chronic Conditions Research Network: overview of research contributions and future priorities. Med Care 52 Suppl 3: S15-22.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-83.
19. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, et al. (2008) The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 61: 1234-40.
20. Pope GC, Kautter J, Ellis RP, Ash AS, Ayanian JZ, et al. (2004) Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Financ Rev 25: 119-41.
21. Goodell S, Druss BG, Reisinger Walker E (2011) Mental disorders and medical comorbidity: Robert Wood Johnson Foundation; February 2011.
22. Soni A (2009) The Five Mostly Costly Children's Conditions, 2006: Estimates for the U.S. Civilian Noninstitutionalized Children, Ages 0-17.Rockville MD: Agency for Healthcare Research and Quality; April 2009.
23. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-9.
24. Ash AS, Ellis RP, Pope GC, Ayanian JZ, Bates DW, et al. (2000) Using diagnoses to describe populations and predict costs. Health Care Financ Rev 21: 7-28.
25. Duan N, Manning WG, Morris CN, Newhouse JP (1984) Choosing Between the Sample Selection Model and the Multi-Part Model Journal of Business and Economic Statistics 2: 283-9.
26. Koenker R, Hallock KF (2001) Quantile Regression. Journal of Economic Perspectives 15: 143-56.
27. Wilcox VL, Kasl SV, Berkman LF (1994) Social support and physical disability in older people after hospitalization: a prospective study. Health Psychol 13: 170-9.
28. Christakis NA, Allison PD (2006) Mortality after the hospitalization of a spouse. N Engl J Med 354: 719-30.
29. Hirsch CH, Sommers L, Olsen A, Mullen L, Winograd CH (1990) The natural history of functional morbidity in hospitalized older patients. J Am Geriatr Soc 38: 1296-303.
30. Sager MA, Franke T, Inouye SK, Landefeld CS, Morgan TM, et al. (1996) Functional outcomes of acute medical illness and hospitalization in older persons. Arch Intern Med 156: 645-52.
31. Maciejewski ML, Liu CF, Derleth A, McDonell M, Anderson S, et al. (2005) The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures. Health services research 40: 887-904.
32. Fleishman JA, Cohen JW (2010) Using information on clinical conditions to predict high-cost patients. Health services research 45: 532-52.
33. Haas LR, Takahashi PY, Shah ND, Stroebel RJ, Bernard ME, et al. (2013) Risk-Stratification Methods for Identifying Patients for Care Coordination. American Journal of Managed Care 19: 725-32.
34. Ivanova JI, Bergman R, Birnbaum HG, Colice GL, Silverman RA, et al. (2012) Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol 129: 1229-35.
35. Kleinman NL, Brook RA, Ramachandran S (2009) An employer perspective on annual employee and dependent costs for pediatric asthma. Ann Allergy Asthma Immunol 103: 114-20.
36. Ramirez M, Chang DC, Bickler SW (2013) Pediatric injury outcomes in racial/ethnic minorities in California: diversity may reduce disparity. JAMA surgery 148: 76-80.
37. Goetzel RZ, Ozminkowski RJ, Villagra VG, Duffy J (2005) Return on investment in disease management: a review. Health Care Financ Rev 26: 1-19.
38. Holtz-Eakin D (13 Oct 2004) An Analysis of the LIterature on Disease Management Programs. Washington DC: Congressional Budget Office.
39. Nelson L (2012) Lessons from Medicare's Demonstration Projects on Disease Management, Care Coordination and Value-Based-Payment. Health and Human Resources Division, Congressional Budget Office. January 2012.
40. Ofman JJ, Badamgarav E, Henning J, Knight K, Gano AD Jr, et al. (2004) Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Medicine 117: 182-92.
41. McCall N, Cromwell J, Smith K, Urato C (2011) Evaluation of Medicare Care Management for High Cost Beneficiaries (CMHCB) Demonstration: The Health Buddy Consortium (HBC) Centers for Medicare & Medicaid Services, Office of Research, Development, and Information.
42. Yoon J, Zulman D, Scott JY, Maciejewski ML (2014) Costs associated with multimorbidity among VA patients. Med Care 52 Suppl 3: S31-6.
43. Health and Human Services (15 Aug 2012) Identifying and stratifying inidviduals with multiple chronic conditions for care management: HHS MCC Strategic Framework. Washington DC: Health and Human Services.
44. Gold JP, Charlson ME, Williams-Russo P, Szatrowski TP, Peterson JC, et al. (1995) Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high vs. low mean arterial pressures. J Thorac Cardiovasc Surg 110: 1302-14.
45. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34: 73-84.
46. R Development Core Team (2011) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. URL http://www.R-project.org.